Middle East & Africa Lidocaine Ointment Market

Middle East & Africa Lidocaine Ointment Market Size & Growth (2024 to 2029)

As Per the Report, the Size of the Lidocaine Ointment Market in the Middle East & Africa was valued at USD 72.76 Million in 2023 and is expected to reach USD 99.55 Million by 2029, to grow at a CAGR of 6.47% during the predicted period 2024 to 2029.

Over the several years, there has been a tremendous increase in the number of surgeries performed globally, including in several regions in the MEA. Significant demand for postoperative pain relief options immediately following an increasing number of surgeries is a critical trend. This trend is expected to impact the market for lidocaine ointment positively. This trend is expected to influence the need for lidocaine ointment positively.

Lidocaine ointment finds its use in dental procedures, cosmetic surgeries, and plastic surgeries, among several other acute or chronic pain-related disorders. Therefore, the increase in dental procedures is expected to boost the market growth, especially in Middle Eastern countries.

The incidence of dental disorders and the increasing number of surgeries performed is the primary determining factor for market growth. In 2020, the most significant predicted age group in the United Arab Emirates was 30 to 34; around 1.8 million people had dental issues.

Additionally, lidocaine ointments are available over the counter to treat chronic and acute pain disorders such as shingles, hemorrhoids, and mouth ulcers, which is expected to stimulate the MEA lidocaine ointment market growth over the forecast period.

However, the application of lidocaine ointment includes various side effects such as redness, tingling, vomiting, and susceptibility to surface infection. Furthermore, due to a wide variety of lidocaine ointments, the market has stiff competition coupled with the rise of counterfeit products; all these factors mentioned above will harm the growth of the MEA lidocaine ointment market.

This research report on the Middle East & Africa Lidocaine Ointment Market has been segmented and sub-segmented into the following categories.

By Formulation

• Internal Use
• Topical Use

By Application

• Medical
• Cosmetics

By Country

• KSA
• UAE
• Israel
• the rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the UAE lidocaine ointment market is dominated by the MEA region. A growing number of dental and plastic surgical procedures and the availability of various products in the region are driving the market in the UAE. For women, liposuction is currently the most attractive cosmetic surgery in the UAE. As a result, it has increased the health spending and the number of patients needing post-surgical pain relief ointment.

The Saudi Arabia lidocaine ointment market is anticipated to experience the fastest market of about 4.12% during the projected period. This growth can be linked to the increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and awareness about beauty and plastic surgeries options.

According to a recent update by the International Society of Cosmetic Plastic Surgeons, KSA holds the 22 ranks for countries with the most cosmetic procedures globally. Moreover, even teenagers have started to perform these procedures. According to the American Society of Plastic Surgeons statistics, 235,000 cosmetic procedures were performed on women under 18 in 2011. In addition, the increase in the geriatric population is expected to drive the number of surgeries performed in the region, promising growth opportunities during the forecast period.

KEY MARKET PLAYERS

Key Market Companies operating the Middle East & Africa Lidocaine Ointment Market Profiled in the Report are AstraZeneca Plc., Glenmark Pharmaceuticals, Teligent, Inc., Proficient Rx LP, ., Septodont Healthcare India Pvt. Ltd., Gemini Pharmaceuticals, Amneal Pharmaceuticals LLC, Taro Pharmaceuticals U.S.A. Inc., Novocol Inc. and Centura Pharmaceuticals, Inc.,